Chicago Trust’s Medpace MEDP Stock Holding History

Chicago Trust’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-839	Closed	-$202K	–	294
2023 Q2	$202K	Buy	+839	New	+$174K	0.05%	293

Other funds holding MEDP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Chicago Trust's MEDP Position: Q3 2023 in Review

Chicago Trust sold out of Medpace (MEDP) in Q3 2023, closing a stake of 839 shares — an estimated $202K sold.

Chicago Trust first reported a position in MEDP in Q2 2023 and held it in 1 quarter. The position peaked at $202K in Q2 2023. 488 funds tracked by Wall St. Rank hold MEDP as of Q3 2023.

Chicago Trust reported no remaining Medpace position as of Q3 2023 after selling out during the quarter.
Chicago Trust sold 839 Medpace shares in Q3 2023, an estimated $202K.
Chicago Trust first reported a position in Medpace in Q2 2023 and held it in 1 quarter.
Chicago Trust's Medpace position peaked at $202K in Q2 2023.
488 funds tracked by Wall St. Rank held Medpace as of Q3 2023.

Based on Chicago Trust's 13F filing for Q3 2023, filed 27 Oct 2023.